Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia

Movement Disorders

Volumn 15, Issue 2, 2000, Pages 352-355

  Rapaport, Abraham ^a,b   Sadeh, Menachem ^a,b   Stein, Daniel ^b   Levine, Joseph ^c   Sirota, Pinhas ^b,d   Mosheva, Tania ^b,d   Stir, Shaul ^b,d   Elitzur, Avner ^b,d   Reznik, Ilia ^b,d   Geva, Diklah ^a   Rabey, J Martin ^b,e  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MENTAL HEALTH CENTER   (Israel)

^d ABARBANEL MENTAL HEALTH CENTER   (Israel)

^e ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; BOTULINUM TOXIN A; BUTYROPHENONE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; PHENOTHIAZINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DYSARTHRIA; DYSPHAGIA; FACE DISORDER; FEMALE; FLU LIKE SYNDROME; HUMAN; INFECTION; KERATITIS; MALE; MASTICATORY MUSCLE; OROFACIAL DYSKINESIA; PAIN; PARESIS; PRIORITY JOURNAL; SIDE EFFECT; TARDIVE DYSKINESIA;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BOTULINUM TOXIN TYPE A; DYSKINESIA, DRUG-INDUCED; FACIAL MUSCLES; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; SCHIZOPHRENIA;

EID: 19244382065     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200003)15:2<352::AID-MDS1030>3.0.CO;2-X     Document Type: Article

References (10)

1. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
2. Mauriello JA Jr, Leone T, Dhilon S, Pakeman B, Mostafavi R, Yepez MC. Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996;98:213-216.
3. Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short and long-term local and systemic effects. Surv Ophthalmol 1996;41:51-65.
4. Chatterjee A, Forrest GM, Giladi N, Trosch R. Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol 1997; 17:497-498.
5. Yasufuku-Takano J, Sakurai M, Kanazawa I, Nagoka M. Successful treatment of intractable tardive dyskinesia with botulinum toxin. J Neurol Neurosurg Psychiatry 1995;58:511-512.
6. Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol 1995;18:197-214.
7. Egan MF, Apud J, Wyatt RJ. Treatment of tardive dyskinesia. Schizophr Bull 1997;23:583-609.
8. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press, 1994.
9. Abnormal Involuntary Movement Scale (AIMS) and Tardive Dyskinesia Rating Scale (TDRS). Psychopharmacol Bull 1988;24: 781-783.
10. Borodic GE. Hemifacial spasm, evaluation and management with emphasis on botulinum toxin therapy. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Taxin. New York, NY: Marcel Dekker, 1994:331-353.